Communiqués EURO BIOT

Actions

EBAC

KYG3167F1028

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 26/06/2024			Varia. 5j.	Varia. 1 janv.
11,85 ^USD	+0,21 %		+0,85 %	+5,90 %

2023	Oculis SA a achevé l'acquisition de European Biotech Acquisition Corp. (NasdaqCM:EBAC) auprès de Lsp Sponsor Ebac B.V. et autres dans le cadre d'une fusion inversée.	CI
2023	European Biotech Acquisition Corp. annonce ses résultats pour l'année complète se terminant le 31 décembre 2022	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

EUROPEAN BIOTECH ACQUISITION CORP. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	28/02/23	AQ
EUROPEAN BIOTECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	28/02/23	AQ
EUROPEAN BIOTECH ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	21/02/23	AQ
EUROPEAN BIOTECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	30/01/23	AQ
EUROPEAN BIOTECH ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14/12/22	AQ
EUROPEAN BIOTECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/11/22	AQ
European Biotech Acquisition : Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology - Form 8-K	17/10/22	PU
EUROPEAN BIOTECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	17/10/22	AQ
EUROPEAN BIOTECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	15/08/22	AQ
EUROPEAN BIOTECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	16/05/22	AQ
EUROPEAN BIOTECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	31/03/22	AQ
EUROPEAN BIOTECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23/11/21	AQ
EUROPEAN BIOTECH ACQUISITION CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	23/11/21	AQ
EUROPEAN BIOTECH ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	18/08/21	AQ
EUROPEAN BIOTECH ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22/06/21	AQ
European Biotech Acquisition Corp. : Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report	04/06/21	BU
European Biotech Acquisition : Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report (Form 8-K)	04/06/21	PU
EUROPEAN BIOTECH ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	04/06/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Sécurisez et Augmentez les Rendements de vos Investissements grâce à l'Accompagnement de Nos Experts

Sécuriser mes Investissements

fermer